Anthera Pharmaceuticals, Inc.
ANTH
$0.0001
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Net Income | 20.15% | -53.37% | -2,115.02% | 102.79% | 13.69% |
| Total Depreciation and Amortization | 360.00% | -14.63% | -74.38% | 255.56% | 80.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.25% | 373.17% | 91.61% | -582.27% | 38.08% |
| Change in Net Operating Assets | -220.92% | 102.00% | 130.55% | 49.41% | -892.43% |
| Cash from Operations | -49.86% | -1.00% | 38.71% | 29.42% | -17.18% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 526.60% | 111.93% | 83.50% | -95.67% | 3,515.86% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 526.60% | 111.93% | 83.50% | -95.67% | 4,388.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 251.80% | 23.55% | 46.58% | -4,874.35% | 98.37% |